These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 9359706)

  • 1. Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line.
    Bedwell DM; Kaenjak A; Benos DJ; Bebok Z; Bubien JK; Hong J; Tousson A; Clancy JP; Sorscher EJ
    Nat Med; 1997 Nov; 3(11):1280-4. PubMed ID: 9359706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminoglycoside suppression of a premature stop mutation in a Cftr-/- mouse carrying a human CFTR-G542X transgene.
    Du M; Jones JR; Lanier J; Keeling KM; Lindsey JR; Tousson A; Bebök Z; Whitsett JA; Dey CR; Colledge WH; Evans MJ; Sorscher EJ; Bedwell DM
    J Mol Med (Berl); 2002 Sep; 80(9):595-604. PubMed ID: 12226741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study.
    Sermet-Gaudelus I; Renouil M; Fajac A; Bidou L; Parbaille B; Pierrot S; Davy N; Bismuth E; Reinert P; Lenoir G; Lesure JF; Rousset JP; Edelman A
    BMC Med; 2007 Mar; 5():5. PubMed ID: 17394637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations.
    Howard M; Frizzell RA; Bedwell DM
    Nat Med; 1996 Apr; 2(4):467-9. PubMed ID: 8597960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel amino-carbonitrile-pyrazole identified in a small molecule screen activates wild-type and ΔF508 cystic fibrosis transmembrane conductance regulator in the absence of a cAMP agonist.
    Namkung W; Park J; Seo Y; Verkman AS
    Mol Pharmacol; 2013 Sep; 84(3):384-92. PubMed ID: 23788656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction of CFTR malfunction and stimulation of Ca-activated Cl channels restore HCO3- secretion in cystic fibrosis bile ductular cells.
    Zsembery A; Jessner W; Sitter G; Spirlí C; Strazzabosco M; Graf J
    Hepatology; 2002 Jan; 35(1):95-104. PubMed ID: 11786964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of CFTR premature termination codons and rescue of CFTR protein and function by the synthetic aminoglycoside NB54.
    Rowe SM; Sloane P; Tang LP; Backer K; Mazur M; Buckley-Lanier J; Nudelman I; Belakhov V; Bebok Z; Schwiebert E; Baasov T; Bedwell DM
    J Mol Med (Berl); 2011 Nov; 89(11):1149-61. PubMed ID: 21779978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations.
    Wilschanski M; Yahav Y; Yaacov Y; Blau H; Bentur L; Rivlin J; Aviram M; Bdolah-Abram T; Bebok Z; Shushi L; Kerem B; Kerem E
    N Engl J Med; 2003 Oct; 349(15):1433-41. PubMed ID: 14534336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial correction of endogenous DeltaF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing.
    Liu X; Jiang Q; Mansfield SG; Puttaraju M; Zhang Y; Zhou W; Cohn JA; Garcia-Blanco MA; Mitchell LG; Engelhardt JF
    Nat Biotechnol; 2002 Jan; 20(1):47-52. PubMed ID: 11753361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical doses of amikacin provide more effective suppression of the human CFTR-G542X stop mutation than gentamicin in a transgenic CF mouse model.
    Du M; Keeling KM; Fan L; Liu X; Kovaçs T; Sorscher E; Bedwell DM
    J Mol Med (Berl); 2006 Jul; 84(7):573-82. PubMed ID: 16541275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No detectable improvements in cystic fibrosis transmembrane conductance regulator by nasal aminoglycosides in patients with cystic fibrosis with stop mutations.
    Clancy JP; Rowe SM; Bebok Z; Aitken ML; Gibson R; Zeitlin P; Berclaz P; Moss R; Knowles MR; Oster RA; Mayer-Hamblett N; Ramsey B
    Am J Respir Cell Mol Biol; 2007 Jul; 37(1):57-66. PubMed ID: 17347447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystic fibrosis transmembrane conductance regulator (CFTR) nucleotide-binding domain 1 (NBD-1) and CFTR truncated within NBD-1 target to the epithelial plasma membrane and increase anion permeability.
    Clancy JP; Hong JS; Bebök Z; King SA; Demolombe S; Bedwell DM; Sorscher EJ
    Biochemistry; 1998 Oct; 37(43):15222-30. PubMed ID: 9790686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-Specific RNA Editing of Stop Mutations in the CFTR mRNA of Human Bronchial Cultured Cells.
    Chiavetta RF; Titoli S; Barra V; Cancemi P; Melfi R; Di Leonardo A
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
    Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
    J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cl transport in complemented CF bronchial epithelial cells correlates with CFTR mRNA expression levels.
    Illek B; Maurisse R; Wahler L; Kunzelmann K; Fischer H; Gruenert DC
    Cell Physiol Biochem; 2008; 22(1-4):57-68. PubMed ID: 18769032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SLC26A9 is a constitutively active, CFTR-regulated anion conductance in human bronchial epithelia.
    Bertrand CA; Zhang R; Pilewski JM; Frizzell RA
    J Gen Physiol; 2009 Apr; 133(4):421-38. PubMed ID: 19289574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic therapy for stop mutations: how much CFTR activity is enough?
    Kerem E
    Curr Opin Pulm Med; 2004 Nov; 10(6):547-52. PubMed ID: 15510065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open reading frame correction using splice-switching antisense oligonucleotides for the treatment of cystic fibrosis.
    Michaels WE; Pena-Rasgado C; Kotaria R; Bridges RJ; Hastings ML
    Proc Natl Acad Sci U S A; 2022 Jan; 119(3):. PubMed ID: 35017302
    [No Abstract]   [Full Text] [Related]  

  • 19. PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model.
    Du M; Liu X; Welch EM; Hirawat S; Peltz SW; Bedwell DM
    Proc Natl Acad Sci U S A; 2008 Feb; 105(6):2064-9. PubMed ID: 18272502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of W1282X CFTR activity by enhanced expression.
    Rowe SM; Varga K; Rab A; Bebok Z; Byram K; Li Y; Sorscher EJ; Clancy JP
    Am J Respir Cell Mol Biol; 2007 Sep; 37(3):347-56. PubMed ID: 17541014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.